Allergan unit sues Mylan over constipation drug
03-04-2018
Sun Pharma sued over IBS generic drug
04-07-2017
stock_colors / iStockphoto.com
Allergan and Ironwood Pharmaceuticals have reached a settlement with India-based Aurobindo Pharma, resolving litigation over a generic version of a constipation drug.
You need a subscription to continue reading this content.
Start a subscription today to access the LSIPR website.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
Aurobindo, Allergan, Ironwood Pharmaceuticals, ANDA, patent infringement, litigation, generics, settlement
